Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 38

1.

Amplification of Oncolytic Vaccinia Virus Widespread Tumor Cell Killing by Sunitinib through Multiple Mechanisms.

Kim M, Nitschké M, Sennino B, Murer P, Schriver BJ, Bell A, Subramanian A, McDonald CE, Wang J, Cha H, Bourgeois-Daigneault MC, Kirn DH, Bell JC, De Silva N, Breitbach CJ, McDonald DM.

Cancer Res. 2018 Feb 15;78(4):922-937. doi: 10.1158/0008-5472.CAN-15-3308. Epub 2017 Dec 19.

2.

Poxvirus-Based Active Immunotherapy with PD-1 and LAG-3 Dual Immune Checkpoint Inhibition Overcomes Compensatory Immune Regulation, Yielding Complete Tumor Regression in Mice.

Foy SP, Sennino B, dela Cruz T, Cote JJ, Gordon EJ, Kemp F, Xavier V, Franzusoff A, Rountree RB, Mandl SJ.

PLoS One. 2016 Feb 24;11(2):e0150084. doi: 10.1371/journal.pone.0150084. eCollection 2016.

3.

Magnetic resonance imaging of stem cell apoptosis in arthritic joints with a caspase activatable contrast agent.

Nejadnik H, Ye D, Lenkov OD, Donig JS, Martin JE, Castillo R, Derugin N, Sennino B, Rao J, Daldrup-Link H.

ACS Nano. 2015 Feb 24;9(2):1150-60. doi: 10.1021/nn504494c. Epub 2015 Jan 26.

4.

Combination strategy targeting VEGF and HGF/c-met in human renal cell carcinoma models.

Ciamporcero E, Miles KM, Adelaiye R, Ramakrishnan S, Shen L, Ku S, Pizzimenti S, Sennino B, Barrera G, Pili R.

Mol Cancer Ther. 2015 Jan;14(1):101-10. doi: 10.1158/1535-7163.MCT-14-0094. Epub 2014 Nov 7.

5.

Iron administration before stem cell harvest enables MR imaging tracking after transplantation.

Khurana A, Chapelin F, Beck G, Lenkov OD, Donig J, Nejadnik H, Messing S, Derugin N, Chan RC, Gaur A, Sennino B, McDonald DM, Kempen PJ, Tikhomirov GA, Rao J, Daldrup-Link HE.

Radiology. 2013 Oct;269(1):186-97. doi: 10.1148/radiol.13130858. Epub 2013 Jul 12.

6.

Inhibition of c-Met reduces lymphatic metastasis in RIP-Tag2 transgenic mice.

Sennino B, Ishiguro-Oonuma T, Schriver BJ, Christensen JG, McDonald DM.

Cancer Res. 2013 Jun 15;73(12):3692-703. doi: 10.1158/0008-5472.CAN-12-2160. Epub 2013 Apr 10.

7.

MR imaging features of gadofluorine-labeled matrix-associated stem cell implants in cartilage defects.

Nejadnik H, Henning TD, Do T, Sutton EJ, Baehner F, Horvai A, Sennino B, McDonald D, Meier R, Misselwitz B, Link TM, Daldrup-Link HE.

PLoS One. 2012;7(12):e49971. doi: 10.1371/journal.pone.0049971. Epub 2012 Dec 12.

8.

Identification of pY654-β-catenin as a critical co-factor in hypoxia-inducible factor-1α signaling and tumor responses to hypoxia.

Xi Y, Wei Y, Sennino B, Ulsamer A, Kwan I, Brumwell AN, Tan K, Aghi MK, McDonald DM, Jablons DM, Chapman HA.

Oncogene. 2013 Oct 17;32(42):5048-57. doi: 10.1038/onc.2012.530. Epub 2012 Dec 17.

9.

Controlling escape from angiogenesis inhibitors.

Sennino B, McDonald DM.

Nat Rev Cancer. 2012 Oct;12(10):699-709. doi: 10.1038/nrc3366. Review.

10.

Suppression of tumor invasion and metastasis by concurrent inhibition of c-Met and VEGF signaling in pancreatic neuroendocrine tumors.

Sennino B, Ishiguro-Oonuma T, Wei Y, Naylor RM, Williamson CW, Bhagwandin V, Tabruyn SP, You WK, Chapman HA, Christensen JG, Aftab DT, McDonald DM.

Cancer Discov. 2012 Mar;2(3):270-87. doi: 10.1158/2159-8290.CD-11-0240. Epub 2012 Feb 24.

11.

Magnetic resonance imaging of ferumoxide-labeled mesenchymal stem cells in cartilage defects: in vitro and in vivo investigations.

Henning TD, Gawande R, Khurana A, Tavri S, Mandrussow L, Golovko D, Horvai A, Sennino B, McDonald D, Meier R, Wendland M, Derugin N, Link TM, Daldrup-Link HE.

Mol Imaging. 2012 Jun;11(3):197-209.

12.

Permeability to macromolecular contrast media quantified by dynamic MRI correlates with tumor tissue assays of vascular endothelial growth factor (VEGF).

Cyran CC, Sennino B, Fu Y, Rogut V, Shames DM, Chaopathomkul B, Wendland MF, McDonald DM, Brasch RC, Raatschen HJ.

Eur J Radiol. 2012 May;81(5):891-6. doi: 10.1016/j.ejrad.2011.07.016. Epub 2011 Sep 1.

13.

Increased vascular delivery and efficacy of chemotherapy after inhibition of platelet-derived growth factor-B.

Falcon BL, Pietras K, Chou J, Chen D, Sennino B, Hanahan D, McDonald DM.

Am J Pathol. 2011 Jun;178(6):2920-30. doi: 10.1016/j.ajpath.2011.02.019.

14.

VEGF and c-Met blockade amplify angiogenesis inhibition in pancreatic islet cancer.

You WK, Sennino B, Williamson CW, Falcón B, Hashizume H, Yao LC, Aftab DT, McDonald DM.

Cancer Res. 2011 Jul 15;71(14):4758-68. doi: 10.1158/0008-5472.CAN-10-2527. Epub 2011 May 25.

15.

MR signal characteristics of viable and apoptotic human mesenchymal stem cells in matrix-associated stem cell implants for treatment of osteoarthritis.

Nedopil A, Klenk C, Kim C, Liu S, Wendland M, Golovko D, Schuster T, Sennino B, McDonald DM, Daldrup-Link HE.

Invest Radiol. 2010 Oct;45(10):634-40. doi: 10.1097/RLI.0b013e3181ed566c.

16.

Labeling human mesenchymal stem cells with fluorescent contrast agents: the biological impact.

Boddington SE, Sutton EJ, Henning TD, Nedopil AJ, Sennino B, Kim A, Daldrup-Link HE.

Mol Imaging Biol. 2011 Feb;13(1):3-9. doi: 10.1007/s11307-010-0322-0.

17.

Two is better than one: benefits of VEGF and PDGF inhibition in ovarian cancer.

Sennino B.

Cancer Biol Ther. 2010 Feb;9(3):183-5. Epub 2010 Feb 4. No abstract available.

PMID:
20083903
18.

An optical imaging method to monitor stem cell migration in a model of immune-mediated arthritis.

Sutton EJ, Boddington SE, Nedopil AJ, Henning TD, Demos SG, Baehner R, Sennino B, Lu Y, Daldrup-Link HE.

Opt Express. 2009 Dec 21;17(26):24403-13. doi: 10.1364/OE.17.024403.

19.

[Effects of MRI-assayed microvascular permeability on the accumulation of vinorelbine in xenograft tumors].

Raatschen HJ, Fu Y, Rogut V, Simon GH, Sennino B, Wolf KJ, Brasch RC.

Rofo. 2010 Feb;182(2):133-9. doi: 10.1055/s-0028-1109753. Epub 2009 Oct 27. German.

PMID:
19862658
20.

The influence of ferucarbotran on the chondrogenesis of human mesenchymal stem cells.

Henning TD, Sutton EJ, Kim A, Golovko D, Horvai A, Ackerman L, Sennino B, McDonald D, Lotz J, Daldrup-Link HE.

Contrast Media Mol Imaging. 2009 Jul-Aug;4(4):165-73. doi: 10.1002/cmmi.276.

21.

Correlative dynamic contrast MRI and microscopic assessments of tumor vascularity in RIP-Tag2 transgenic mice.

Sennino B, Raatschen HJ, Wendland MF, Fu Y, You WK, Shames DM, McDonald DM, Brasch RC.

Magn Reson Med. 2009 Sep;62(3):616-25. doi: 10.1002/mrm.22040.

22.

Cellular source and amount of vascular endothelial growth factor and platelet-derived growth factor in tumors determine response to angiogenesis inhibitors.

Sennino B, Kuhnert F, Tabruyn SP, Mancuso MR, Hu-Lowe DD, Kuo CJ, McDonald DM.

Cancer Res. 2009 May 15;69(10):4527-36. doi: 10.1158/0008-5472.CAN-08-3779. Epub 2009 Apr 28.

23.

Relaxation effects of ferucarbotran-labeled mesenchymal stem cells at 1.5T and 3T: discrimination of viable from lysed cells.

Henning TD, Wendland MF, Golovko D, Sutton EJ, Sennino B, Malek F, Bauer JS, McDonald DM, Daldrup-Link H.

Magn Reson Med. 2009 Aug;62(2):325-32. doi: 10.1002/mrm.22011.

24.

Magnetic resonance imaging for monitoring the effects of thalidomide on experimental human breast cancers.

Cyran CC, Sennino B, Chaopathomkul B, Fu Y, Rogut VS, Shames DM, Wendland MF, McDonald DM, Brasch RC.

Eur Radiol. 2009 Jan;19(1):121-31. doi: 10.1007/s00330-008-1111-x. Epub 2008 Jul 30.

25.

Soluble receptor-mediated selective inhibition of VEGFR and PDGFRbeta signaling during physiologic and tumor angiogenesis.

Kuhnert F, Tam BY, Sennino B, Gray JT, Yuan J, Jocson A, Nayak NR, Mulligan RC, McDonald DM, Kuo CJ.

Proc Natl Acad Sci U S A. 2008 Jul 22;105(29):10185-90. doi: 10.1073/pnas.0803194105. Epub 2008 Jul 16.

26.

Magnetic resonance imaging assays for dimethyl sulfoxide effect on cancer vasculature.

Cyran CC, Sennino B, Chaopathomkul B, Fu Y, Rogut V, Shames DM, Wendland MF, McDonald DM, Brasch RC.

Invest Radiol. 2008 May;43(5):298-305. doi: 10.1097/RLI.0b013e318164b71d.

27.

Vascular permeability during antiangiogenesis treatment: MR imaging assay results as biomarker for subsequent tumor growth in rats.

Raatschen HJ, Simon GH, Fu Y, Sennino B, Shames DM, Wendland MF, McDonald DM, Brasch RC.

Radiology. 2008 May;247(2):391-9. doi: 10.1148/radiol.2472070363. Epub 2008 Mar 27.

28.

Sequential loss of tumor vessel pericytes and endothelial cells after inhibition of platelet-derived growth factor B by selective aptamer AX102.

Sennino B, Falcón BL, McCauley D, Le T, McCauley T, Kurz JC, Haskell A, Epstein DM, McDonald DM.

Cancer Res. 2007 Aug 1;67(15):7358-67.

29.

Cell labeling with the positive MR contrast agent Gadofluorine M.

Henning TD, Saborowski O, Golovko D, Boddington S, Bauer JS, Fu Y, Meier R, Pietsch H, Sennino B, McDonald DM, Daldrup-Link HE.

Eur Radiol. 2007 May;17(5):1226-34. Epub 2007 Jan 6.

PMID:
17206428
30.

Rapid vascular regrowth in tumors after reversal of VEGF inhibition.

Mancuso MR, Davis R, Norberg SM, O'Brien S, Sennino B, Nakahara T, Yao VJ, Inai T, Brooks P, Freimark B, Shalinsky DR, Hu-Lowe DD, McDonald DM.

J Clin Invest. 2006 Oct;116(10):2610-21.

31.

VEGF-dependent plasticity of fenestrated capillaries in the normal adult microvasculature.

Kamba T, Tam BY, Hashizume H, Haskell A, Sennino B, Mancuso MR, Norberg SM, O'Brien SM, Davis RB, Gowen LC, Anderson KD, Thurston G, Joho S, Springer ML, Kuo CJ, McDonald DM.

Am J Physiol Heart Circ Physiol. 2006 Feb;290(2):H560-76. Epub 2005 Sep 19.

32.

Cellular changes in normal blood capillaries undergoing regression after inhibition of VEGF signaling.

Baffert F, Le T, Sennino B, Thurston G, Kuo CJ, Hu-Lowe D, McDonald DM.

Am J Physiol Heart Circ Physiol. 2006 Feb;290(2):H547-59. Epub 2005 Sep 19.

33.

Osteopontin (Eta-1) and fibroblast growth factor-2 cross-talk in angiogenesis.

Leali D, Dell'Era P, Stabile H, Sennino B, Chambers AF, Naldini A, Sozzani S, Nico B, Ribatti D, Presta M.

J Immunol. 2003 Jul 15;171(2):1085-93.

34.

Distinct role of fibroblast growth factor-2 and vascular endothelial growth factor on tumor growth and angiogenesis.

Giavazzi R, Sennino B, Coltrini D, Garofalo A, Dossi R, Ronca R, Tosatti MP, Presta M.

Am J Pathol. 2003 Jun;162(6):1913-26.

35.

Gene expression profile in fibroblast growth factor 2-transformed endothelial cells.

Dell'Era P, Coco L, Ronca R, Sennino B, Presta M.

Oncogene. 2002 Apr 4;21(15):2433-40.

36.

Modulation of tumor angiogenesis by conditional expression of fibroblast growth factor-2 affects early but not established tumors.

Giavazzi R, Giuliani R, Coltrini D, Bani MR, Ferri C, Sennino B, Tosatti MP, Stoppacciaro A, Presta M.

Cancer Res. 2001 Jan 1;61(1):309-17.

37.

Thrombospondin-1/HIV-1 tat protein interaction: modulation of the biological activity of extracellular Tat.

Rusnati M, Taraboletti G, Urbinati C, Tulipano G, Giuliani R, Molinari-Tosatti MP, Sennino B, Giacca M, Tyagi M, Albini A, Noonan D, Giavazzi R, Presta M.

FASEB J. 2000 Oct;14(13):1917-30.

PMID:
11023976
38.

Effect of organic cosolvents on the stability and activity of the beta-1,4-galactosyltransferase from bovine colostrum.

Riva S, Sennino B, Zambianchi F, Danieli B, Panza L.

Carbohydr Res. 1997 Dec;305(3-4):525-31.

PMID:
9648270

Supplemental Content

Loading ...
Support Center